$1.69
-0.0100 (-0.588%)
At Close: Jul 31, 2026
EDEN PRAIRIE, Minn. , April 18, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
EDEN PRAIRIE, Minn., March 3, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ca
NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q1 2022 Results - Earnings Call Transcript
06:35pm, Monday, 14'th Feb 2022
NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q1 2022 Results - Earnings Call Transcript
NeuroOne posts data from initial long-term testing of thin film electrode technology
03:58pm, Tuesday, 08'th Feb 2022 Seeking Alpha
NeuroOne Medical Technologies <> is trading higher after announcing that the company successfully concluded initial pre-clinical testing designed to assess the long-term…
NeuroOne Medical Technologies Corp Shares Approach 52-Week Low - Market Mover
12:53pm, Thursday, 06'th Jan 2022 Kwhen Finance
NeuroOne Medical Technologies Corp (NMTC) shares closed today at 1.1% above its 52 week low of $1.82, giving the company a market cap of $29M. The stock is currently down 5.2% year-to-date, up 234.5% over the past 12 months, and up 234.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 25.6% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 15168.0% The company's stock price performance over the past 12 months beats the peer average by -2465.7%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.
NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q4 2021 Earnings Call Transcript
11:32am, Wednesday, 15'th Dec 2021
NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q4 2021 Earnings Call Transcript
NeuroOne to Host Fourth Quarter 2021 Earnings Call
06:55pm, Monday, 06'th Dec 2021 Benzinga
EDEN PRAIRIE, Minn. , Dec. 6, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC ) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today it will host a conference call to discuss financial results for its fourth quarter and fiscal year ended September 30, 2021 , on December 15, 2021 , at 9:00 AM Eastern Time . Conference Call Information Event Date: Full story available on Benzinga.com
NeuroOne to Host Fourth Quarter 2021 Earnings Call
01:55pm, Monday, 06'th Dec 2021
EDEN PRAIRIE, Minn., Dec. 6, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ca
NeuroOne: Thin Film Electrodes For Diagnosis And Treatment Of Neurological Conditions
11:54am, Friday, 19'th Nov 2021
NeuroOne is a developer of flexible, minimally invasive, thin film electrodes for cEEG and sEEG recording, and the diagnosis and treatment of neurological conditions. Mayo Clinic is a key development
NeuroOne Medical Technologies (OTCMKTS:NMTC) Research Coverage Started at Craig Hallum
10:22am, Thursday, 18'th Nov 2021 Dakota Financial News
Craig Hallum started coverage on shares of NeuroOne Medical Technologies (OTCMKTS:NMTC) in a research note released on Monday morning, The Fly reports. The firm issued a buy rating and a $6.00 price objective on the stock. NeuroOne Medical Technologies stock opened at $2.55 on Monday. NeuroOne Medical Technologies has a 1 year low of $2.50 []
NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock
08:02am, Wednesday, 13'th Oct 2021
EDEN PRAIRIE, Minn., Oct. 13, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the "Company"), a medical technology company focused on improving surgical care options an
NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock
07:03pm, Tuesday, 12'th Oct 2021
EDEN PRAIRIE, Minn., Oct. 12, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the "Company"), a medical technology company focused on improving surgical care options an
NeuroOne® Medical Technologies Corporation Announces Successful Completion of Feasibility Study for Ablation Electrode
09:00am, Thursday, 23'rd Sep 2021
EDEN PRAIRIE, Minn., Sept. 23, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care
NeuroOne® Medical Technologies Corporation Receives FDA 510(k) Clearance for its Evo® sEEG Electrode
02:21pm, Tuesday, 07'th Sep 2021
EDEN PRAIRIE, Minn., Sept. 7, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care
NeuroOne Featured on Cheddar News (VIDEO): "Can This Brain Implant Save Lives?"
11:00am, Wednesday, 25'th Aug 2021
EDEN PRAIRIE, Minn., Aug. 25, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care
Sign In
Buy NMTC